HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma mycoides subspecies mycoides small colony type.

Abstract
Minimum inhibitory concentrations (MIC) and minimum mycoplasmacidal concentrations (MMC) of the antimicrobials danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin were determined in vitro for 20 isolates of Mycoplasma mycoides subspecies mycoides small colony type (MmmSC), the causative agent of contagious bovine pleuropneumonia (CBPP). The majority of strains were most susceptible to tilmicosin, followed by danofloxacin, oxytetracycline, florfenicol and spectinomycin with MIC50 values of 0.015, 0.25, 0.5, 1 and 8 microg/ml, and MMC50 values of 0.06, 0.5, 8, 8 and 16 microg/ml, respectively. However, tilmicosin had poor mycoplasmacidal activity against two recent strains from Portugal. There was no evidence of resistance to danofloxacin in any of the strains.
AuthorsR D Ayling, S E Baker, R A Nicholas, M L Peek, A J Simon
JournalThe Veterinary record (Vet Rec) Vol. 146 Issue 9 Pg. 243-6 (Feb 26 2000) ISSN: 0042-4900 [Print] England
PMID10737293 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Macrolides
  • danofloxacin
  • Spectinomycin
  • florfenicol
  • Thiamphenicol
  • Oxytetracycline
  • tilmicosin
  • Tylosin
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Cattle
  • Cattle Diseases (drug therapy, microbiology)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Microbial
  • Fluoroquinolones
  • Macrolides
  • Mycoplasma mycoides (drug effects)
  • Oxytetracycline (pharmacology)
  • Pleuropneumonia, Contagious (drug therapy)
  • Spectinomycin (pharmacology)
  • Thiamphenicol (analogs & derivatives, pharmacology)
  • Tylosin (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: